Type 1 Diabetes TrialNet
@T1D_TrialNet
TrialNet offers free risk screening for relatives of people with type 1 diabetes and innovative clinical studies. Our goal: a future without T1D!
We’re wrapping up #ADA2025 with “Celebrating NIDDK's 75th Anniversary—Clinical, Translational & Basic Advances, Current Research Priorities & Future Direction” where #TrialNet investigator Jeffrey Krischer @USFHealth will present “Today's Reality of Achieving Type 1 Prevention”
TrialNet in the News: Dr. Abha Choudhary, from UT Southwestern, was recently interviewed by T1D Exchange to discuss exciting research!
T1D symptoms are caused by high blood sugar levels (glucose) and may be mistaken for severe flu or another illness. T1D develops over time. TrialNet aims to prevent type 1 diabetes before these symptoms occur. Get screened at trialnet.org/participate
Add it to your calendar now! TrialNet will be at these upcoming T1D events offering risk screening for anyone interested. Contact us to learn more about risk screening or other screening events near you. You can register online for free risk screening at trialnet.org/participate
Type 1 diabetes (T1D) is an autoimmune disease that progresses in three stages. The immune system mistakenly attacks and destroys healthy insulin producing cells, called beta cells. TrialNet is working to change that. Sign up for free screening at trialnet.org/participate
To learn more about the eligibility criteria for autoantibody risk screening, visit our website at trialnet.org/participate
Thursday 11-12 | Managing Sick Days and Stress Days Friday 9-10 | Current Research for Prevention and Delay of Type 1 Diabetes Friday 1:30-2:30 | In Case You Missed It: Speed Dating with FFL Faculty The TrialNet team will also be screening for T1D risk daily at Toluca A.
Last year more than 100 people were screened at Friends for Life to learn their risk of type 1 diabetes! Learn more from the TrialNet team located at Toluca A.
TrialNet screens families of people with T1D & offers clinical studies testing ways to slow down & prevent disease progression. Our free at-home screening kits can be shipped anywhere in the US & Canada.
Type 1 diabetes (T1D) knows no boundaries—but access to screening and post-diagnostic care does. [1,2] Adolescents and young adults in rural communities are at greater risk of delayed diagnosis of T1D, often presenting with life-threatening diabetic ketoacidosis (DKA). [2]…
Exciting news! TrialNet will be at these upcoming T1D events offering risk screening for anyone interested. Contact us to learn more about risk screening or other screening events near you. You can also register online for free risk screening at trialnet.org/participate
Newly diagnosed with Type 1 Diabetes? Join our enrolling study JAKPOT T1D tailored for individuals recently diagnosed with T1D. Visit: trialnet.org/jakpot
This afternoon at #ADA2025 Jason Gaglia @JoslinDiabetes presents #TrialNet research poster 726-P “Two-Year Follow-up of AVT001 Dendritic Cell Therapy for Type 1 Diabetes—Continued Off-Therapy Functional Effects and Characterization of Responders”
You won’t want to miss this afternoon’s #ADA2025 Poster Session where Heba Ismail @IUMedSchool will present #TrialNet research poster 1525-P “Genetic Ancestry and Progression through Type 1 Diabetes (T1D) Stages”
Start your day off with #ADA2025 Symposium “Continuous Ketone Monitoring—Innovations and clinical Applications” where #TrialNet researcher Jennifer Sherr @YaleIMed will present “Ketone Sensor Performance Criteria and Current Study Data”
Day 3: Our researchers have already participated in more than a dozen sessions at #ADA2025 sharing data critical to moving #type1diabetes prevention and #T1D treatment forward. @AmDiabetesAssn
Be sure to stop by #TrialNet booth #1048 in the #ADA2025 Exhibitor’s Hall for more information on #TrialNet #T1Dresearch and how to #screen4T1D @AmDiabetesAssn